Protein kinase cAMP-activated catalytic subunit alpha (PRKACA)-mediated phosphorylation of MORC2 on T582 abrogates CMA-mediated degradation of MORC2, leading to endocrine resistance of breast cancer cells [124]. This evidence concerns the gene MORC2 and breast carcinoma.